MEAK7 and hepatocellular carcinoma: The examination of the function of Mammalian Enhancer-of-Akt-1-7 (mEAK-7) in mTORC1 signaling reveals that S6K2 promotes cell proliferation and migration in response to mTOR activation in various cancer types, such as hepatocellular carcinoma and lymph node-positive breast cancers [39].